These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 805253)

  • 1. Control of local tumor growth with combined fractionated radiotherapeutic and chemotherapeutic regimens.
    Poulakos L; Schenken LL; Hagemann RF; Burholt DR; Lesher S
    J Natl Cancer Inst; 1975 May; 54(5):1103-5. PubMed ID: 805253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of solid P815x2 murine mastocytoma with adriamycin (NSC-1231127): toxity limitations.
    Schenken LL; Poulakos L; Hagemann RF; Burholt D; Lesher S
    J Natl Cancer Inst; 1976 Mar; 56(3):683-5. PubMed ID: 815561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined-modality oncotherapy with cyclophosphamide (NSC-26271) and radiotherapy: control of murine mastocytoma.
    Schenken LL; Hagemann RF; Burholt DR; Lesher S
    J Natl Cancer Inst; 1976 Oct; 57(4):943-9. PubMed ID: 826650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative character and growth modes of neoplastic disease as determinants of chemotherapeutic efficacy.
    Schenken LL
    Cancer Treat Rep; 1976 Dec; 60(12):1761-76. PubMed ID: 829040
    [No Abstract]   [Full Text] [Related]  

  • 5. A murine Wilms' tumor as a model for chemotherapy and radiotherapy.
    Tomashefsky P; Homsy YL; Lattimer JK; Tannenbaum M
    J Natl Cancer Inst; 1976 Jan; 56(1):137-42. PubMed ID: 176375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of an experimental solid tumour to irradiation: A comparison of modes of fractionation.
    Schenken LL; Poulakos L; Hagemann RF
    Br J Cancer; 1975 Feb; 31(2):228-36. PubMed ID: 809050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of 5-hydroxyindoles as an indicator of in vivo growth of P815X2 mastocytoma.
    Raikow RB; Schenken LL; Lesher S
    Eur J Cancer (1965); 1976 Dec; 12(12):1011-5. PubMed ID: 827448
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.
    Buchsbaum DJ; Zhou T; Grizzle WE; Oliver PG; Hammond CJ; Zhang S; Carpenter M; LoBuglio AF
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3731-41. PubMed ID: 14506165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
    Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
    Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL; Roberts D
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combined treatment with nimustine hydrochloride and radiation on solid FM3A tumor in mice.
    Shimizu F; Inomata T; Mizuno H; Arakawa M; Ogata T; Okawa T
    Jpn J Cancer Res; 1987 Jul; 78(7):756-62. PubMed ID: 3114202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats.
    Bartholeyns J; Koch-Weser J
    Cancer Res; 1981 Dec; 41(12 Pt 1):5158-61. PubMed ID: 6796266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple drug chemotherapy combined with multiple fractions per day (MFD) radiotherapy in an experimental solid tumor model.
    Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED
    In Vivo; 1994; 8(1):107-12. PubMed ID: 8054501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination adriamycin-radiation treatment of pulmonary tumors in mice.
    Shaeffer J; EL-Mahdi AM
    Oncology; 1981; 38(1):35-8. PubMed ID: 6934455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--I. Adriamycin.
    Twentyman PR; Kallman RF; Brown JM
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1255-60. PubMed ID: 528273
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of tumor regrowth to tumor cell survival, tumor cure rates and host survival in a solid tumor model following combined chemotherapy and radiotherapy.
    Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED
    In Vivo; 1994; 8(1):97-105. PubMed ID: 8054518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. III. Morphometric assessment of the dynamic changes in post-capillary venules as regulatory elements of lymphocyte recirculation in tumor-draining lymph nodes.
    Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R
    Arch Geschwulstforsch; 1987; 57(1):7-15. PubMed ID: 3105513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.